Table 1 Demographic, clinical and cognitive characteristics of T2DM patients with or without MCI

Age (year)

62 (56–68)

58 (52–64)

<0.001^b*

Female (n, %)

207 (41.6)

117 (49.8)

90 (34.4)

<0.001^c*

Education

10 (9–12)

9 (6–12)

12 (9–12)

<0.001^b*

BMI (Kg/m²)

24.77 (22.77–27.04)

24.57 (22.77–27.12)

24.80 (22.75–26.86)

0.869^b

DM Duration (year)

10 (5–14)

10 (5–15)

10 (5–13)

0.352^b

HBP Duration (year)

3 (0–10)

5 (0–15)

1 (0–10)

0.006^b*

Smoking (n, %)

178 (35.8)

79 (33.6)

99 (37.8)

0.333^c

Statins (n, %)

265 (53.3)

133 (56.6)

132 (50.4)

0.166^c

Other Antilipidemic Drugs (n, %)

24 (4.8)

15 (6.4)

9 (3.4)

0.126^c

HbA1c (%)

8.60 (7.20–10.30)

8.80 (7.50–10.50)

8.40 (7.10–10.10)

0.090^b

TG (mmol/l)

1.48 (1.04–2.27)

1.53 (1.00–2.38)

1.48 (1.05–2.18)

0.599^b

TC (mmol/l)

4.60 ± 1.15

4.67 ± 1.24

4.54 ± 1.07

0.196^a

HDL-C (mmol/l)

1.15 (1.00–1.34)

1.16 (1.01–1.34)

1.15 (0.98–1.32)

0.300^b

LDL-C (mmol/l)

2.82 (2.29–3.43)

2.85 (2.23–3.63)

2.81 (2.32–3.24)

0.475^b

LDL-C/HDL-C

2.43 (2.00–2.95)

2.43 (1.98–3.03)

2.42 (2.01–2.91)

0.819^b

MoCA

26 (23–27)

22 (20–24)

27 (26–28)

<0.001^b*

DST

12 (10–13)

11 (9–12)

12 (11–14)

<0.001^b*

VFT

16 (14–19)

15 (13–18)

18 (15–21)

<0.001^b*

CDT

4 (3–4)

3 (2–4)

4 (3–4)

<0.001^b*

TMTA

60 (49–83)

71 (57–95)

55 (45–67)

<0.001^b*

TMTB

160 (123–205)

185 (145–236)

135 (106–178)

<0.001^b*